ReviewNanomedicine (London, England)2025
Emerging self-assembled peptide hydrogels for enhanced wound healing.
Review in Nanomedicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Antibacterial and Wound-Healing Efficacy of 12-Hydroxylauric Acid-Conjugated Heterochiral Diphenylalanines: Insights From In Vitro and In Vivo Investigations.Chembiochem : a European journal of chemical biology · 2026Article
- Peptide-Based Nanogels for Pharmaceutical and Biotechnological Applications: From Fmoc-FF to Other Peptide Sequences.Pharmaceuticals (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wound healing, particularly in chronic conditions such as diabetic ulcers, burns, and pressure injuries, represents a highly intricate and clinically challenging process. These wounds frequently exhibit persistent pathological inflammation, disrupting conventional healing trajectories and significantly compromising patient well-being. Consequently, the development of innovative therapeutic interventions is urgently needed. Self-assembling peptide-based hydrogels have emerged as novel biomaterials, demonstrating exceptional promise in wound management. This article reviews recent advancements in the design and application of self-assembling peptide-based hydrogels, with a focused analysis of their roles in antibacterial activity, hemostasis, and enhancing tissue regeneration. Engineered to exhibit injectability, controlled drug release, spatiotemporal targeting, stimuli-responsive behavior, and biocompatibility, these hydrogels enable precise, dynamic, and patient-tailored therapeutic strategies. By integrating peptide self-assembly with biomedical insights, this article highlights how peptide-based hydrogels address critical limitations in conventional wound care, offering scalable solutions to improve healing outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.